KAITLYN WHYMAN: Open Payments
NPI 1720769185 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$199 in 4 payments from 4 companies in 2025. Trend: 2023 $203 · 2024 $387 · 2025 $199
Food & beverage: $199
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 1 | $122 |
| Ipsen Biopharmaceuticals, Inc | 1 | $26 |
| Incyte Corporation | 1 | $26 |
| Syndax Pharmaceuticals, Inc. | 1 | $26 |
Products named: KEYTRUDA, Onivyde, NIKTIMVO.
Industry payments across MD — which companies pay providers there.
